Syndax Pharmaceuticals, Inc.
SNDXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $1.21B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $12.80$25.59
- Volume (live)
- -
- Avg. volume (3M)
- 2.23M
Syndax Pharmaceuticals (SNDX) Stock Price & Financial Analysis
Syndax Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $13.20 - $13.61 |
|---|---|
| 52-Week High | $25.59 |
| 52-Week Low | $12.80 |
| Open | $13.60 |
| Volume (last close) | 4.25M |
| Average Volume (3M) | 2.23M |
| Revenue (TTM) | 252.00M |
|---|---|
| Net Income (TTM) | -220.76M |
| Free Cash Flow (TTM) | -220.87M |
| EPS (TTM) | −$2.52 |
| Profit Margin | -87.60% |
| Operating Margin | -77.05% |
| Return on Equity (ROE) | -1462.12% |
| Debt to Equity | 38.98 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.21B |
|---|---|
| Shares Outstanding | 88.99M |
| Price to Sales (P/S) | 4.79 |
| Price to Book (P/B) | 79.98 |
| EV/EBITDA | -10.79 |
| 50-Day MA | $18.18 |
|---|---|
| 200-Day MA | $20.53 |
| 1-Year Change | −7.56% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Syndax Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Syndax Pharmaceuticals (SNDX) has a market capitalization of $1.21B. The stock trades at 4.8× sales. Over the trailing twelve months it lost $220.76M on revenue of $252.00M and burned $220.87M of free cash flow. Revenue grew 222.7% year over year.
As of its latest reported balance sheet, it holds $336.48M in cash and securities against $588.62M of debt, a net debt position of $252.15M.
Syndax Pharmaceuticals does not currently pay a dividend.
The share price is down 7.6% over the past year. At $13.40 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $12.79 to $25.59, below its 200-day moving average of $20.53.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $38.29, 185.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Syndax Pharmaceuticals
What is the current stock price for SNDX?
As of the Oct 23, 2026 close, SNDX stock trades at $13.40. The 52-week range is $12.80–$25.59, with a day range of $13.20–$13.61.
What is the P/E ratio for SNDX?
The P/E ratio (Price-to-Earnings) for SNDX is shown in the Key Statistics section. This valuation metric helps compare Syndax Pharmaceuticals, Inc. to industry peers.
Does SNDX pay dividends?
Syndax Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SNDX?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for SNDX is Buy. The average 12-month price target is $38.29, a 185.7% upside from the Oct 23, 2026 close of $13.40.
What is the market cap of SNDX?
As of the Oct 23, 2026 close, Syndax Pharmaceuticals's market capitalization is $1.19B, classifying it as a small-cap company. Syndax Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.